Chunxia Liu

Title: Innovations of Chunxia Liu

Introduction

Chunxia Liu is a prominent inventor based in Nanjing, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for treating diabetes and metabolic syndrome. With a total of 2 patents, her work showcases her dedication to advancing medical science.

Latest Patents

Chunxia Liu's latest patents include the "Long-acting oxyntomodulin hybrid peptide, preparation method therefor, and application thereof." This invention discloses a polypeptide that modifies oxyntomodulin (OXM) by hybridizing it with a peptide sequence of Exenatide. The modification enables the polypeptide to resist DPP-4 enzyme degradation through amino acid changes, while also conjugating fatty acid chains. This results in an OXM hybrid peptide that has a longer pharmacologic action time and improved weight loss effects. The synthesis of this target polypeptide is achieved through an orthogonal protection strategy solid-phase synthesis method, followed by purification and freeze-drying to obtain the OXM hybrid peptide.

Another significant patent is the "Phenoxyacetic acid derivatives, preparation method thereof and use thereof as medicament." This invention relates to a novel phenoxyacetic acid derivative, which has shown excellent in vivo hypoglycemic activity. The derivative can be utilized in pharmaceutical compositions for preventing or treating diabetes and metabolic syndrome.

Career Highlights

Chunxia Liu is affiliated with China Pharmaceutical University, where she continues her research and development efforts. Her work has garnered attention for its innovative approach to addressing critical health issues.

Collaborations

Chunxia Liu collaborates with notable colleagues, including Hai Qian and Wenlong Huang, who contribute to her research endeavors.

Conclusion

Chunxia Liu's contributions to the field of pharmaceuticals through her innovative patents highlight her role as a leading inventor in the industry. Her work not only advances scientific knowledge but also has the potential to improve the lives of individuals suffering from diabetes and metabolic syndrome.